Synthetic mucins shed light on cancer biology and tumor formation

During cold and flu season, excess mucus is a common, unpleasant symptom of illness, but the slippery substance is essential to human health.

New compounds from fungi show promise in treating colorectal cancer

Novel chemical compounds from a fungus could provide new perspectives for treating colorectal cancer, one of the most common and deadliest cancers worldwide.

October 17, 2024

Pharmalittle: Opaque conflicts permeate prescription drug benefits; Sanofi prevails in Zantac arbitration

Rise and shine, everyone, another busy day is on the way. We can tell by the number of people walking past and cars whizzing by

June 20, 2023

Benchstrength Closes $62M Early-Stage VC Fund with Healthcare Focus

What You Should Know: – Benchstrength, a New York City-based venture capital firm, has announced the close of its first $62M fund, focused on investing

December 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.